sitagliptin-phosphate and Leukopenia

sitagliptin-phosphate has been researched along with Leukopenia* in 1 studies

Other Studies

1 other study(ies) available for sitagliptin-phosphate and Leukopenia

Article	Year
Severe leucopenia associated with Sitagliptin use. Diabetes research and clinical practice, 2011, Volume: 91, Issue:2 We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment. Topics: Aged; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Leukopenia; Male; Pyrazines; Sitagliptin Phosphate; Triazoles	2011

Article

Year

Severe leucopenia associated with Sitagliptin use.

Diabetes research and clinical practice, 2011, Volume: 91, Issue:2

We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment.

Topics: Aged; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Leukopenia; Male; Pyrazines; Sitagliptin Phosphate; Triazoles

2011